MannKind (Nasdaq: MNKD) announced that the U.S. Food & Drug Administration (FDA) has approved AFREZZA (insulin human) Inhalation Powder to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE